Kusajili – Clinical trials directory

Result of your search per sponsor: Francois DREYFUS, MD PhD

Woman and Man Max 99 years
Francois DREYFUS, MD PhD Update Il y a 4 ans

Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes We are evaluating the efficacy of the association of Low dose Cytarabine in association with Bortezomib in the treatment of patients diagnosed with high risk Myelodysplastic syndromes. Our...

Country France
organs None
Specialty None

unknown

More information